133 related articles for article (PubMed ID: 19188550)
1. Bosentan decreases pulmonary vascular resistance and improves exercise capacity in acute hypoxia.
Faoro V; Boldingh S; Moreels M; Martinez S; Lamotte M; Unger P; Brimioulle S; Huez S; Naeije R
Chest; 2009 May; 135(5):1215-1222. PubMed ID: 19188550
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary artery pressure limits exercise capacity at high altitude.
Naeije R; Huez S; Lamotte M; Retailleau K; Neupane S; Abramowicz D; Faoro V
Eur Respir J; 2010 Nov; 36(5):1049-55. PubMed ID: 20378601
[TBL] [Abstract][Full Text] [Related]
3. Endothelin receptors blockade blunts hypoxia-induced increase in PAP in humans.
Pham I; Wuerzner G; Richalet JP; Peyrard S; Azizi M
Eur J Clin Invest; 2010 Mar; 40(3):195-202. PubMed ID: 20415698
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
Ghofrani HA; Reichenberger F; Kohstall MG; Mrosek EH; Seeger T; Olschewski H; Seeger W; Grimminger F
Ann Intern Med; 2004 Aug; 141(3):169-77. PubMed ID: 15289213
[TBL] [Abstract][Full Text] [Related]
5. Effects of acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitudes.
Faoro V; Huez S; Giltaire S; Pavelescu A; van Osta A; Moraine JJ; Guenard H; Martinot JB; Naeije R
J Appl Physiol (1985); 2007 Oct; 103(4):1161-5. PubMed ID: 17615281
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity?
Schuuring MJ; Vis JC; Bouma BJ; van Dijk AP; van Melle JP; Pieper PG; Vliegen HW; Sieswerda GT; Mulder BJ
Contemp Clin Trials; 2011 Jul; 32(4):586-91. PubMed ID: 21527360
[TBL] [Abstract][Full Text] [Related]
7. Dietary nitrate improves muscle but not cerebral oxygenation status during exercise in hypoxia.
Masschelein E; Van Thienen R; Wang X; Van Schepdael A; Thomis M; Hespel P
J Appl Physiol (1985); 2012 Sep; 113(5):736-45. PubMed ID: 22773768
[TBL] [Abstract][Full Text] [Related]
8. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
9. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
Galiè N; Beghetti M; Gatzoulis MA; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
Circulation; 2006 Jul; 114(1):48-54. PubMed ID: 16801459
[TBL] [Abstract][Full Text] [Related]
10. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.
Hebert A; Mikkelsen UR; Thilen U; Idorn L; Jensen AS; Nagy E; Hanseus K; Sørensen KE; Søndergaard L
Circulation; 2014 Dec; 130(23):2021-30. PubMed ID: 25446057
[TBL] [Abstract][Full Text] [Related]
11. Effects of sildenafil on exercise capacity in hypoxic normal subjects.
Faoro V; Lamotte M; Deboeck G; Pavelescu A; Huez S; Guenard H; Martinot JB; Naeije R
High Alt Med Biol; 2007; 8(2):155-63. PubMed ID: 17584010
[TBL] [Abstract][Full Text] [Related]
12. Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.
Barst RJ; Mubarak KK; Machado RF; Ataga KI; Benza RL; Castro O; Naeije R; Sood N; Swerdlow PS; Hildesheim M; Gladwin MT;
Br J Haematol; 2010 May; 149(3):426-35. PubMed ID: 20175775
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil and bosentan improve arterial oxygenation during acute hypoxic exercise: a controlled laboratory trial.
Olfert IM; Loeckinger A; Treml B; Faulhaber M; Flatz M; Burtscher M; Truebsbach S; Kleinsasser A
Wilderness Environ Med; 2011 Sep; 22(3):211-21. PubMed ID: 21723164
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic bosentan does not improve exercise capacity or lower pulmonary artery systolic pressure at high altitude.
Seheult RD; Ruh K; Foster GP; Anholm JD
Respir Physiol Neurobiol; 2009 Feb; 165(2-3):123-30. PubMed ID: 18977464
[TBL] [Abstract][Full Text] [Related]
15. Effects of sildenafil on the human response to acute hypoxia and exercise.
Ricart A; Maristany J; Fort N; Leal C; Pagés T; Viscor G
High Alt Med Biol; 2005; 6(1):43-9. PubMed ID: 15772499
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary vascular reserve and exercise capacity at sea level and at high altitude.
Pavelescu A; Faoro V; Guenard H; de Bisschop C; Martinot JB; Mélot C; Naeije R
High Alt Med Biol; 2013 Mar; 14(1):19-26. PubMed ID: 23537256
[TBL] [Abstract][Full Text] [Related]
17. Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects.
Valentini M; Revera M; Bilo G; Caldara G; Savia G; Styczkiewicz K; Parati S; Gregorini F; Faini A; Branzi G; Malfatto G; Magrì D; Agostoni P; Parati G
Cardiovasc Ther; 2012 Aug; 30(4):240-8. PubMed ID: 21883997
[TBL] [Abstract][Full Text] [Related]
18. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.
Berger RM; Beghetti M; Galiè N; Gatzoulis MA; Granton J; Lauer A; Chiossi E; Landzberg M
Int J Cardiol; 2010 Oct; 144(3):373-8. PubMed ID: 19464064
[TBL] [Abstract][Full Text] [Related]
19. Bosentan for increased pulmonary vascular resistance in a patient with single ventricle physiology and a bidirectional Glenn shunt.
Votava-Smith JK; Perens GS; Alejos JC
Pediatr Cardiol; 2007; 28(4):314-6. PubMed ID: 17563825
[TBL] [Abstract][Full Text] [Related]
20. Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function.
Pearl JM; Wellmann SA; McNamara JL; Lombardi JP; Wagner CJ; Raake JL; Nelson DP
Ann Thorac Surg; 1999 Nov; 68(5):1714-21; discussion 1721-2. PubMed ID: 10585047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
